
Migraine is not just a severe headache. It is an attack that can put you out of action for half a day or longer - with nausea, vomiting, sensitivity to light and sound, and often visual aura. Anyone who experiences this regularly - several times a month - is looking for anything that will genuinely reduce the frequency or shorten the duration of attacks.
Medical cannabis can be that something - but honestly: not for everyone and not in every situation. Below we explain how cannabis affects migraine from a physiological standpoint, what the research says (and what we still don't know), which forms and doses make sense, and when the risks outweigh the benefits.
The endocannabinoid system (ECS) is a network of receptors and neurotransmitters distributed throughout the nervous system and internal organs. It regulates, among other things, the pain threshold, inflammatory states, vascular tone, and serotonin release - precisely the mechanisms involved in triggering a migraine attack.
Neurologist Ethan Russo formulated the hypothesis of Clinical Endocannabinoid Deficiency (CECD): in some people with chronic migraine, fibromyalgia, or irritable bowel syndrome, the endocannabinoid system functions below the level seen in healthy individuals. The endogenous cannabinoid anandamide shows tonic activity in the periaqueductal grey (a brain structure that generates migraine attacks) and modulates serotonin transmission. When anandamide levels are too low, the pain threshold drops and attacks occur more frequently.
THC and CBD act on exactly this system: THC activates CB1 receptors (inhibiting pain transmission and relieving nausea), while CBD modulates serotonin receptors and exerts anti-inflammatory effects without psychoactivity. Together, they may - at least in some patients - compensate for the deficiency that underlies migraine.
Medical cannabis is used for migraine in two distinct ways - and it is important to understand the difference:
Which approach makes sense depends on the clinical picture: how often you have attacks, how quickly they escalate, what medications you are already taking, and whether you are prone to analgesic overuse. Your doctor discusses all of this during the initial consultation. For more on specific preparations and dosing, see the article on forms of administration of medical cannabis.
The evidence for the effectiveness of medical cannabis in migraine is early and primarily observational - we do not yet have large, randomised controlled trials (RCTs), which are the gold standard.
A cross-sectional Israeli study (PMC, 2020) of 145 migraine patients using medical cannabis found that in approximately 61% of participants, attacks decreased by at least half compared with the pre-treatment period. The median treatment duration was three years. The study has significant limitations: small sample size, no control group, subjective measurement (questionnaire), and potential selection bias (patients already committed to this therapy).
A systematic review published in Frontiers in Neurology (2022) pooled results from multiple observational studies and confirmed that medical cannabis terminated attacks in some patients and reduced their frequency - but the authors highlighted the absence of high-quality RCTs as the main limitation of the entire field.
In short: the data are promising enough to justify treatment in appropriate patients, but insufficient to state that cannabis works for migraine as reliably as triptans or established preventive medications.
Several forms of medical cannabis are used for migraine - each has a different onset time and a different effect profile:
Dosing for migraine starts low - the start low, go slow principle is especially important here, because too high a THC dose in sensitive individuals can paradoxically trigger or worsen a headache. Specific doses are determined by the doctor, gradually titrating upward until a therapeutic effect is achieved. Read more about this in the article on microdosing medical cannabis and the general piece on dosing.
This is the most important trap in migraine and cannabis treatment.
Medication Overuse Headache (MOH) is a condition in which excessively frequent use of analgesics - triptans, NSAIDs, paracetamol - paradoxically worsens headaches. The patient takes medication to get rid of the pain, and the pain returns faster and more intensely.
A study published in Neurology (AAN 2021) found that the use of medical cannabis is associated with a significantly higher rate of MOH in patients with chronic migraine - the odds ratio was nearly 6 compared with non-cannabis users. The association was bidirectional: patients using cannabis also took opioid analgesics more frequently.
What this means in practice: if someone reaches for cannabis (or other analgesics) more than 10-15 times per month, they risk entering the MOH spiral. Cannabis will not fix existing MOH - the overused medications must first be withdrawn, often under neurological supervision.
This is why the doctor at your appointment will always ask about your previous treatment and how often you take analgesics - it is not a formality, it is a prerequisite for safe therapy.
In the Israeli study, 37% of patients reported adverse effects - most commonly neurological (drowsiness, dizziness), less often psychological (anxiety, paranoia at higher THC doses). Notably, adverse effects were more frequent in non-responders (46%) than in successfully treated patients (30%).
Cannabis treatment for migraine is not appropriate for:
The THC-to-CBD ratio matters for the side-effect profile - a higher proportion of CBD relative to THC is generally better tolerated at the start of treatment. Read more in the article on THC:CBD ratios.
An honest summary for people with migraine who are considering cannabis:
Is your migraine accompanied by significant tension-type pain? That involves a somewhat different mechanism - also read about cannabis for tension headaches and about migraine among other headache types in the article on cluster headache. We discuss the full topic of pain in the article on medical cannabis for chronic pain.
To obtain a prescription for medical cannabis in Poland, you need an appointment with a doctor licensed to issue one. At CannabisMedic, appointments take place in person - in Krakow, Bydgoszcz, Torun, and Kielce.
The initial qualifying appointment costs 169 PLN and typically lasts 20-30 minutes. The doctor (Dr Olha Kompaniiets or Dr Shelest) takes a medical history, evaluates your existing migraine treatment, and - if you qualify - selects a preparation and issues an e-prescription on the spot.
It is worth bringing: - documentation of your previous treatment (if available - for example, results from a neurologist) - a list of medications you are currently taking - an approximate number of migraine attacks in the past month
The follow-up appointment (after 4-8 weeks) costs 149 PLN and is used to assess the effects, adjust the preparation and dose if needed, and renew the prescription. More about the entire process in the article how to get a prescription for medical cannabis and in the cost breakdown pricing of appointments and preparations in 2026.
Will medical cannabis cure my migraine? No - no method "cures" migraine, as it is a chronic condition. Cannabis may reduce the frequency and severity of attacks in some patients, but not in all and not with certainty.
How long before the preventive effects become noticeable? With regular use of oil, the first changes are sometimes noticeable after 4-8 weeks. The first weeks are often a period of dose adjustment.
Can I combine cannabis with triptans? This is an individual medical decision. Many people combine both - cannabis preventively and triptans acutely for attacks. There are no documented dangerous interactions, but every combination requires medical evaluation.
What about driving? Preparations containing THC may impair the ability to drive. The time during which THC affects reaction speed is individual. Your doctor will advise on safety guidelines.
Do I need a prior migraine diagnosis from a neurologist? This is not a formal requirement, but having neurological documentation facilitates the assessment and selection of therapy. If you have never seen a neurologist for your migraines, it is worth considering doing so in parallel.
Does the same apply to cluster headache, which is even worse than migraine? Cluster headache is a separate condition with a different mechanism. We have written about it separately - see the article on medical cannabis for cluster headache.
Ready to start therapy?
Book online in 60 seconds - consultation at our clinic in Krakow, Bydgoszcz, Toruń or Kielce.
Book a consultation